Latest AI and machine learning research in dermatology for healthcare professionals.
RNA-based cancer immunotherapy has emerged as a next-generation strategy in oncology, harnessing the...
Cyclin-dependent kinase 4/6 inhibitors improve outcomes in hormone receptor-positive, human epiderma...
Multiple Myeloma (MM) is a malignancy that is commonly associated with the development of osteolytic...
INTRODUCTION: Artificial intelligence (AI) is reshaping diagnostic paradigms across oncology. In oph...
Uveal melanoma (UVM) is an aggressive intraocular malignancy with a high risk of metastasis but few ...
Multicellular programs in the tumour microenvironment (TME) drive cancer pathogenesis and response t...
PURPOSE: To increase performance and generalization ability of artificial intelligence prostate canc...
CONTEXT.—: Advances in computer vision have fueled the development of artificial intelligence (AI)-b...
OBJECTIVE: To develop an architecture-agnostic framework that estimates, calibrates, and leverages t...
BACKGROUND: Precise area measurement of body surfaces is essential in clinical trials and clinical p...
INTRODUCTION: We have developed a digital algorithm to assess skin pigmentation, specifically an art...
BACKGROUND: Skin neglected tropical diseases (NTDs) such as cutaneous leishmaniasis, lymphatic filar...
Medication use during adolescence provides important insight into current health and treatment patte...
BACKGROUND: MRI is essential for diagnosing and monitoring neurological diseases. Conventional proto...
Early and accurate detection of plant leaf diseases is an essential requirement for precision agricu...
BACKGROUND: Accurate evaluation of skin lesions is an essential component of dermatological examinat...
BACKGROUND: Melanoma represents a highly aggressive and metastatic form of malignant skin cancer. th...
OBJECTIVES: The aim of this study was to evaluate the feasibility and reproducibility of a novel dee...
The efficacy of PD-1 inhibitor pucotenlimab (HX008) in solid tumors exhibits heterogeneity. This stu...
BACKGROUND: The prediction of Epidermal Growth Factor Receptor (EGFR) mutation status in advanced lu...
Over the past two decades, experimental and clinical evidence has established the interleukin-23 (IL...